Method of preparing iodosilanes and compositions therefrom
US-2021331930-A1 · Oct 28, 2021 · US
US9682866B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9682866-B2 |
| Application number | US-201415105190-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 19, 2014 |
| Priority date | Dec 20, 2013 |
| Publication date | Jun 20, 2017 |
| Grant date | Jun 20, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A neutral complex of a cyclic silane characterized in being represented by the general formula [Y] 1 [Si m Z 2m-a H a ]. (In the formula: Y is at least one kind of coordination compound selected from a group consisting of (1) compounds represented as X 1 R 1 n . (when X 1 is P, P═O or N, n=3 and each R 1 represents a substituted or unsubstituted alkyl group or aryl group and R 1 s are the same or different; when X 1 is S, S═O or O, n=2 and each R 1 represents the same group as described above and R 1 s are the same or different; and the number of amino groups in X 1 R 1 n is 0 or 1), and (2) at least one heterocyclic compound selected from the group consisting of substituted or unsubstituted N—, O—, S —or P— containing heterocyclic compounds that have an unshared electron pair in the ring (the number of amino groups in the heterocyclic compound is 0 or 1), each Z represents a halogen atom of any of Cl, Br, I and F and Zs are the same or different, l is 1 or 2, m is 3 to 8, and a is 0 to m.
Opening claim text (preview).
The invention claimed is: 1. A neutral complex of a cyclic silane represented by the general formula [Y] 1 [Si m Z 2m−a H a ], wherein Y is at least one coordination compound selected from the group consisting of (1) a compound represented as X 1 R 1 n (when X 1 is P, P═O or N, n=3 and each R 1 represents a substituted or unsubstituted alkyl group or aryl group and R 1 s are the same or different; when X 1 is S, S═O or O, n=2 and each R 1 represents the same group as described above and R 1 s are the same or different; and the number of amino groups in X 1 R 1 n is 0 or 1), and (2) at least one heterocyclic compound selected from the group consisting of substituted or unsubstituted N—, O—, S— or P— containing heterocyclic compounds that have an unshared electron pair in the ring (the number of amino groups in the heterocyclic compound is 0 or 1), each Z represents a halogen atom of any of Cl, Br, I and F and Zs are the same or different, l is 1 or 2, m is 3 to 8, and a is 0 to m. 2. The neutral complex of a cyclic silane according to claim 1 , wherein Y in the general formula is at least one compound selected from the group consisting of PR 3 and a substituted or unsubstituted N— containing heterocyclic compound having an unshared electron pair in the ring. 3. The neutral complex of a cyclic silane according to claim 1 , wherein the neutral complex of a cyclic silane contains [Y] l [Si 6 Cl 12 ] (l is 1 or 2). 4. The neutral complex of a cyclic silane according to claim 1 , the neutral complex of a cyclic silane being an intermediate for synthesizing a cyclic hydrogenated silane or a cyclic organic silane. 5. A method for manufacturing a neutral complex of a cyclic silane, comprising a step of conducting a cyclization reaction of a halosilane compound in the presence of at least one coordination compound selected from the group consisting of the following (3) and (4): (3) a compound represented as X 2 R 2 q (when X 2 is P or P═O, q=3 and each R 2 represents a substituted or unsubstituted alkyl group or aryl group and R 2 s are the same or different; when X 2 is S, S═O or O, q=2 and each R 2 represents a substituted or unsubstituted alkyl group or aryl group and R 2 s are the same or different; when X 2 is CN, q=1 and R 2 represents a substituted or unsubstituted alkyl group or aryl group; and the number of amino groups in X 2 R 2 q is 0 or 1); and (4) at least one heterocyclic compound selected from the group consisting of substituted or unsubstituted N—, O—, S—or P— containing heterocyclic compounds that have an unshared electron pair in the ring (the number of amino groups in the heterocyclic compound is 0 or 1). 6. The method for manufacturing a neutral complex of a cyclic silane according to claim 5 , wherein the cyclization reaction is conducted in the presence of a tertiary amine (except a tertiary polyamine). 7. The method for manufacturing a neutral complex of a cyclic silane according to claim 5 , wherein the neutral complex of a cyclic silane contains a neutral complex of dodecachlorocyclohexasilane including the coordination compound(s) coordinated to dodecachlorocyclohexasilane. 8. A method for manufacturing a cyclic hydrogenated silane, comprising a step of reducing the neutral complex of a cyclic silane obtained in the manufacturing method according to claim 5 . 9. The method for manufacturing a cyclic hydrogenated silane according to claim 8 , wherein at least one reducing agent selected from the group consisting of an aluminum-based reducing agent and a boron-based reducing agent is used as a reducing agent in the reduction step. 10. The method for manufacturing a cyclic hydrogenated silane according to claim 8 , wherein the hydride equivalent in the reducing agent relative to one silicon-halogen bond in the neutral complex of a cyclic silane is 0.9 to 2.0 in the reduction step. 11. The method for manufacturing a cyclic hydrogenated silane according to claim 8 , wherein the reduction step is conducted at −198° C. to −10° C. 12. A method for manufacturing a cyclic organic silane, comprising a step of alkylating or arylating the neutral complex of a cyclic silane obtained by the manufacturing method according to claim 5 with at least one reagent selected from the group consisting of a Grighard reagent and an organolithium reagent. 13. The method for manufacturing a neutral complex of a cyclic silane according to claim 5 , wherein an amount of the coordination compound is at least 2.0 mol and up to 50 mol relative to 6 mol of the halosilane compound.
Hydrides of silicon · CPC title
Coating compositions, e.g. paints, varnishes or lacquers, based on inorganic substances · CPC title
Halogenated silanes obtained by disproportionation and molecular rearrangement of halogenated silanes · CPC title
Cyclic compounds having at least one ring containing silicon, but no carbon in the ring · CPC title
Aromatic phosphines (P-C aromatic linkage) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.